46 completed, 20 recruiting, 15 terminated, 15 unknown. 117 Phase 2, 23 Phase 1, 12 Phase 3.
Follow Pharmaceutical Preparations: new trials by email Literature Review of Pharmaceutical Preparations trials Research Report on Pharmaceutical Preparations
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Group PACBT for Depression Psilocybin (drug), Group Cognitive Behavioral Therapy - Depression - Major Depressive Disorder, Psilocybin | Phase 2 | Not yet recruiting | University of California, Los Angeles | 30 | 2027-01-01 | 2026-05-04 |
| Effects of Psilocybin on Craving in Nicotine Dependence Psilocybin (drug) - Nicotine Dependence | Phase 2 | Not yet recruiting | University of British Columbia | 3 | 2027-01-01 | 2026-10-01 |
| Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies Transcranial Magnetic Stimulation, Psilocybin (drug), Neurofeedback - PTSD, PTSD - Post Traumatic Stress Disorder | Phase 2 | Not yet recruiting | University of New Mexico | 150 | 2026-12-31 | 2026-10-30 |
| Efficacy and Safety of Spironolactone in Pediatric Hemodialysis Patients With Anemia. Spironolactone (drug), Iron Supplement, Erythropoietin stimulating agent - Anemia | Phase 2 | Not yet recruiting | Ain Shams University | 40 | 2026-12-01 | 2026-07-20 |
| Regression in Left Ventricular Hypertrophy and Fibrosis in Aortic Stenosis Dapagliflozin (DAPA), Spironolactone (drug), Spironolactone + Dapagliflozin - Aortic Stenosis | Phase 2 | Not yet recruiting | University College, London | 445 | 2026-12-01 | 2026-09-11 |
| NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy Psilocybin (drug), Standard of Care (SOC) - Psilocybin, Neuropathy | Phase 2 | Suspended | M.D. Anderson Cancer Center | 90 | 2026-11-04 | 2026-11-19 |
| Localized Injection of Lidocaine Via the Middle Meningeal Artery for Headache Treatment Lidocaine (drug), Saline - Refractory Migraine, Headache | Phase 2 | Recruiting | Daniel A Tonetti, MD | 80 | 2026-09-09 | 2026-10-01 |
| A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors VMD-102 - Hepatocellular Carcinoma (HCC), Metastatic Uveal Melanoma | Phase 1 / Phase 2 | Recruiting | VM Discovery, Inc. | 111 | 2026-07-16 | 2026-11-03 |
| The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease Psilocybin (drug) - Depression, Parkinson's Disease (PD) | Phase 2 | Recruiting | Yale University | 40 | 2026-07-10 | 2026-11-20 |
| Efficacy and Mechanism of IPSRT for Bipolar II Disorder Quetiapine (drug), Psychopharmacological treatment - Bipolar Disorder II | Phase 2 | Not yet recruiting | First Affiliated Hospital of Zhejiang University | 216 | 2026-07-01 | 2026-06-17 |
| Letrozole Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy Methotrexate (drug), Letrozole 2.5Mg Tab - Ectopic Pregnancy | Phase 2 | Not yet recruiting | Kafrelsheikh University | 70 | 2026-06-01 | 2026-06-03 |
| [18F]F-AraG PET Imaging in Alzheimer's Disease Drug: [18F]F-AraG (PET tracer) - Alzheimer Disease (AD) | Phase 2 | Not yet recruiting | CellSight Technologies, Inc. | 10 | 2026-05-16 | 2026-05-28 |
| Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS) vicadrostat / empagliflozin combination 1, Spironolactone (drug) - CKD, Cardiovascular Diseases | Phase 2 | Recruiting | University Medical Center Groningen | 100 | 2026-05-12 | 2026-05-29 |
| A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression STAR-001 (LP-184) will be administered via IV infusion over 30 (± 5) minutes on Day 1 and Day 8 of each 21-day cycle., Spironolactone (drug) - Glioblastoma (GBM) | Phase 1 / Phase 2 | Not yet recruiting | Starlight Therapeutics Inc. | 68 | 2026-05-01 | 2026-03-30 |
| Combining Latency Reversing Agents to Address the HIV Reservoir Pyrimethamine (PYR), Lenalidomide, Topiramate (drug) - HIV (Human Immunodeficiency Virus), HIV -1 Infection | Phase 1 / Phase 2 | Not yet recruiting | Erasmus Medical Center | 30 | 2026-04-01 | 2026-02-03 |
| To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric Cancer JPI-547, Irinotecan (drug) - Gastric Cancer (GC) | Phase 1 / Phase 2 | Not yet recruiting | Onconic Therapeutics Inc. | 49 | 2026-02-27 | 2026-01-23 |
| RCT of Psilocybin-assisted CBT for Depression Psilocybin (drug), cognitive behavioral therapy, Minimal supportive therapy - Major Depressive Diorder | Phase 1 / Phase 2 | Recruiting | University of California, Los Angeles | 50 | 2026-01-05 | 2026-02-12 |
| A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus First-Line Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma Apatinib, Camrelizumab, TACE - Hepatocellular Carcinoma | Phase 2 / Phase 3 | Not yet recruiting | Shanghai Zhongshan Hospital | 222 | 2025-12-22 | 2025-12-30 |
| Psilocybin Microdosing With Psychotherapy for Treatment-Resistant Depression Psilocybin (drug), Placebo - Treatment Resistant Depression | Phase 2 | Recruiting | Beersheva Mental Health Center | 20 | 2025-12-01 | 2025-11-19 |
| SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety Fluoxetine (drug), Placebo - Hepatobiliary Malignancy, Fluoxetine | Phase 2 | Recruiting | First Affiliated Hospital of Wenzhou Medical University | 240 | 2025-10-01 | 2026-03-24 |
Showing 20 of 117. Sign in to see all of them.
Carcinoma, Hepatocellular (5) · HIV Infections (4) · Neoplasms (4) · Parkinson Disease (4) · Carcinoma, Non-Small-Cell Lung (3) · Furcation Defects (3) · Head and Neck Neoplasms (3) · Lymphoma (3) · Migraine Disorders (3) · Anemia (2) · Anxiety Disorders (2) · Breast Neoplasms (2) · Depression (2) · Fibrosis (2) · Headache (2)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest (6) · University Health Network, Toronto (4) · French National Agency for Research on AIDS and Viral Hepatitis (3) · Government Dental College and Research Institute, Bangalore (3) · University Hospital, Clermont-Ferrand (3) · Yale University (3) · ANRS, Emerging Infectious Diseases (2) · Assistance Publique - Hôpitaux de Paris (2) · Bellus Health Inc. - a GSK company (2) · International Extranodal Lymphoma Study Group (IELSG) (2) · M.D. Anderson Cancer Center (2) · Mayo Clinic (2) · Sun Yat-sen University (2) · University Hospital, Bordeaux (2) · University of California, Los Angeles (2)
United States (33) · France (15) · Germany (15) · Canada (12) · China (8) · Belgium (5) · Netherlands (5) · Australia (4) · Italy (4) · Spain (4) · United Kingdom (4) · India (3) · Poland (3) · South Korea (3) · Switzerland (3)
Genevieve Chene, MD, PhD (3) · Salah-Eddin Al-Batran, Prof. (2) · Salah-Eddin Al-Batran, Prof. Dr. (2) · Stuart D Katz, MD (2) · Susan H Fox, MRCP, PhD (2) · Andre Cantin, md (1) · Andrea C King, PhD (1) · Barry J Byrne, MD, PhD (1) · Bruno Scheller, MD (1) · Caroline Altergott, MD (1) · Caroline Sevin, MD, PhD (1) · Casper Rokx, MD PhD (1) · Cesar Serrano, MD (1) · Channa Jayasekera (1)
PMID 12064356, PMID 15060509, PMID 15456093, PMID 15583741, PMID 15784740, PMID 15890495, PMID 15978266, PMID 16002461, PMID 16194720, PMID 16495395, PMID 17101615, PMID 17119142, PMID 17434849, PMID 17554116, PMID 17591032, PMID 18425621, PMID 18461895, PMID 18536865, PMID 19958860, PMID 20025989, PMID 20819978, PMID 21704313, PMID 22440499, PMID 22585216, PMID 22794786, PMID 23177384, PMID 23190183, PMID 23570273, PMID 25552401, PMID 25568347, PMID 26243227, PMID 26451031, PMID 27712462, PMID 27751554, PMID 27758940, PMID 30800121, PMID 32026447, PMID 34182952, PMID 37821131, PMID 40520457, PMID 40803733, PMID 42254059
2004 (2), 2017 (1), 2025 (1), P01HL059412 (1), P30CA043703 (1), R01DA016834 (1), R01NS046309 (1), R34AT013077 (1), U10CA180886 (1)